Revlon raises capital
This article was originally published in The Rose Sheet
Executive Summary
Cosmetics firm issues $363 mil. in 12% senior secured notes due 2005, Revlon announces. Notes were sold at 96.6% of principal value and proceeds were paid into escrow pending completion of a new credit agreement. Company entered new credit agreement with bank consortium Nov. 30, providing $250 mil. in credit facilities. Net proceeds from offering and credit facility will be used to repay debt, Revlon notes...
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.